← all drugs
Morphine Sulfate Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-10-09
Day 3,265
of this shortage, counting from the FDA's first posting on 10/31/2017
- Manufacturers listed
- Fresenius Kabi USA, LLC, Amphastar Pharmaceuticals, Inc., Hospira, Inc., a Pfizer Company, Hikma Pharmaceuticals USA, Inc., Piramal Critical Care Inc.
- Reported reason(s)
- Other; Demand increase for the drug; Discontinuation of the manufacture of the drug
- Machine-readable
- JSON for this drug
Presentations (24)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1) | Amphastar Pharmaceuticals, Inc. | Available | 10/05/2026 |
| Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25) | Hikma Pharmaceuticals USA, Inc. | unavailable | 09/18/2026 |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02) | Piramal Critical Care Inc. | Available | 09/15/2026 |
| Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02) | Piramal Critical Care Inc. | Available | 09/15/2026 |
| Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-26 — Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- 2026-09-23 — Morphine Sulfate Injection: availability wording revised for 2 presentation(s)
- 2026-09-17 — Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- 2026-09-05 — Morphine Sulfate Injection: availability wording revised for 1 presentation(s)
- 2026-08-27 — Morphine Sulfate Injection: availability wording revised for 2 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.